Chinook Therapeutics Inc (NASDAQ:KDNY)

BATS BZX Real-Time Price
As of 11:27am ET
 +0.89 / +4.24%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Chinook Therapeutics Inc have a median target of 32.50, with a high estimate of 48.00 and a low estimate of 20.00. The median estimate represents a +48.54% increase from the last price of 21.88.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Chinook Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.04%
Growthannually -9.13%


Growthquarterly 11.64%
Growthannually -92.27%
Key to the earnings and sales forecast charts.